Publisher: Karger
E-ISSN: 1661-7819|78|4|277-280
ISSN: 1661-7800
Source: Neonatology, Vol.78, Iss.4, 2000-11, pp. : 277-280
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) administration at 10 μg/kg/day for 15–30 min over 3 consecutive days in 3 preterm neonates with allo-immune neonatal neutropenia (ANN) is reported. Patients 1 and 2 had antibodies against antigen NA2, while patient 3 had antibodies against NA1. All neonates developed a rapid increase in absolute neutrophil count which reached the normal range within 48 h (from 75–640/mm3 to 2,520–4,700/mm3). However, 23–25 days later, all 3 neonates relapsed into a second phase of severe neutropenia (408–870/mm3). Antibodies against neutrophil antigens were still positive during this period. This second-phase neutropenia persisted for 20–30 days and resolved spontaneously. It may be possible that when rhG-CSF is administered within a short time after birth in neonates with ANN, its effect is exhausted before the concentration of circulating antibodies decreases, with the result that a second phase of neutropenia can be expected.
Related content
By Venkateswaran Lakshmi Wilimas Judith A. Dancy Rhonda Wang Winfred C. Korones Sheldon Hayden Jane Hayes F. Ann
Pediatric Hematology and Oncology, Vol. 17, Iss. 6, 2000-09 ,pp. :
By Fioredda Francesca Calvillo Michaela Renga Daniela Bonanomi Sonia Ciliberti Andrea Martire Baldassarre Ghilardi Roberta Dufour Carlo
Pediatric Hematology and Oncology, Vol. 25, Iss. 4, 2008-05 ,pp. :
Messenger RNA Expression of Granulocyte Colony-Stimulating Factor Receptor Isoforms in the Fetus
Neonatology, Vol. 83, Iss. 3, 2003-04 ,pp. :